tiprankstipranks
Trending News
More News >
Kura Oncology (KURA)
NASDAQ:KURA
US Market

Kura Oncology (KURA) Income Statement

Compare
782 Followers

Kura Oncology Income Statement

Last quarter (Q3 2025), Kura Oncology's total revenue was $20.75M, an increase of Infinity% from the same quarter last year. In Q3, Kura Oncology's net income was $-74.12M. See Kura Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 53.88M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 53.88M$ -849.00K$ 0.00$ 0.00$ -194.00K
Operating Expenses
$ 247.08M$ 164.96M$ 139.87M$ 131.26M$ 91.70M
Depreciation and Amortization
$ 848.00K$ 849.00K$ 759.00K$ 558.00K$ 194.00K
EBITDA
$ -169.50M$ -150.23M$ -134.85M$ -129.49M$ -88.85M
Operating Income
$ -193.19M$ -165.80M$ -139.87M$ -131.26M$ -91.90M
Other Income/Expenses
$ 21.23M$ 13.17M$ 4.03M$ 792.00K$ 2.27M
Pretax Income
$ -171.97M$ -152.63M$ -135.84M$ -130.47M$ -89.63M
Net Income
$ -173.98M$ -152.63M$ -135.84M$ -130.47M$ -89.63M
Per Share Metrics
Basic EPS
$ -2.02$ -2.08$ -2.03$ -1.97$ -1.69
Diluted EPS
$ -2.02$ -2.08$ -2.03$ -1.97$ -1.69
Weighted Average Shares Outstanding
86.16M 73.23M 66.99M 66.35M 53.08M
Weighted Average Shares Outstanding (Diluted)
86.16M 73.23M 66.99M 66.35M 53.08M
Currency in USD

Kura Oncology Earnings and Revenue History